Cite
Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs
MLA
Sean E. Hulsebosch, et al. “Ultra-Long-Acting Recombinant Insulin for the Treatment of Diabetes Mellitus in Dogs.” Journal of Veterinary Internal Medicine, vol. 36, no. 4, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....60dd2514166577c9f82f6b24a0c53a49&authtype=sso&custid=ns315887.
APA
Sean E. Hulsebosch, Jully Pires, Michael J. Bannasch, Thomas Lancaster, Andrea Delpero, Ramya Ragupathy, Sylaja Murikipudi, Todd Zion, & Chen Gilor. (2021). Ultra-long-acting recombinant insulin for the treatment of diabetes mellitus in dogs. Journal of Veterinary Internal Medicine, 36(4).
Chicago
Sean E. Hulsebosch, Jully Pires, Michael J. Bannasch, Thomas Lancaster, Andrea Delpero, Ramya Ragupathy, Sylaja Murikipudi, Todd Zion, and Chen Gilor. 2021. “Ultra-Long-Acting Recombinant Insulin for the Treatment of Diabetes Mellitus in Dogs.” Journal of Veterinary Internal Medicine 36 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....60dd2514166577c9f82f6b24a0c53a49&authtype=sso&custid=ns315887.